Another result of immunoneutralization of CCR7 or CCL21 has been shown to reduce pulmonary remodelling in severe combined immunodeficiency CB-17-SCID/bg mice which has been intravenously pre-treated with IPF fibroblasts. This evidence concerns the gene CCL21 and idiopathic pulmonary fibrosis.